AGL 40.10 Decreased By ▼ -0.10 (-0.25%)
AIRLINK 129.00 Decreased By ▼ -0.11 (-0.09%)
BOP 6.54 Decreased By ▼ -0.06 (-0.91%)
CNERGY 4.03 No Change ▼ 0.00 (0%)
DCL 8.35 Decreased By ▼ -0.10 (-1.18%)
DFML 41.74 Increased By ▲ 0.49 (1.19%)
DGKC 86.25 Decreased By ▼ -0.75 (-0.86%)
FCCL 33.40 Increased By ▲ 0.05 (0.15%)
FFBL 65.62 Decreased By ▼ -0.28 (-0.42%)
FFL 10.67 Increased By ▲ 0.13 (1.23%)
HUBC 111.35 Increased By ▲ 0.65 (0.59%)
HUMNL 15.20 Decreased By ▼ -0.03 (-0.2%)
KEL 4.83 Increased By ▲ 0.05 (1.05%)
KOSM 8.06 Increased By ▲ 0.23 (2.94%)
MLCF 41.75 Decreased By ▼ -0.15 (-0.36%)
NBP 60.35 Decreased By ▼ -0.15 (-0.25%)
OGDC 183.02 Increased By ▲ 0.22 (0.12%)
PAEL 25.43 Increased By ▲ 0.07 (0.28%)
PIBTL 7.26 Increased By ▲ 1.00 (15.97%)
PPL 146.40 Decreased By ▼ -1.41 (-0.95%)
PRL 24.57 Increased By ▲ 0.01 (0.04%)
PTC 16.42 Increased By ▲ 0.18 (1.11%)
SEARL 70.50 No Change ▼ 0.00 (0%)
TELE 7.35 Increased By ▲ 0.05 (0.68%)
TOMCL 36.45 Increased By ▲ 0.15 (0.41%)
TPLP 7.88 Increased By ▲ 0.03 (0.38%)
TREET 15.31 Increased By ▲ 0.01 (0.07%)
TRG 52.00 Increased By ▲ 0.30 (0.58%)
UNITY 27.57 Increased By ▲ 0.22 (0.8%)
WTL 1.25 Increased By ▲ 0.02 (1.63%)
BR100 9,861 Increased By 18.7 (0.19%)
BR30 30,033 Decreased By -3.5 (-0.01%)
KSE100 92,870 Increased By 349.6 (0.38%)
KSE30 28,824 Increased By 37.7 (0.13%)

Testing men with prostate cancer for a substance called endoglin in their blood may help doctors know if the cancer has spread outside the gland to the lymph nodes, new research shows.
It is known that removing the pelvic lymph nodes can provide important information about the prognosis of prostate cancer, but "it is still not clear in whom this procedure should be done," researcher Dr Claus G. Roehrborn, from the University of Texas South-western Medical Centre in Dallas, explained in a statement.
Previous research has identified elevated levels of endoglin in patients with breast cancer and colon cancer that has spread, according to the report in the journal Clinical Cancer Research. Whether endoglin levels are increased in prostate cancer patients had never been looked at until now.
Roehrborn's team studied 425 men who underwent surgical removal of the prostate as well as removal of the pelvic lymph nodes. The investigators found that men with elevated endoglin levels were more likely to have cancer that had spread to the lymph nodes, as well as other signs of more aggressive cancer.
With standard factors, the researchers could predict with 89 percent accuracy whether the cancer had spread to the lymph nodes. When the endoglin measurement was included, the accuracy rose to 98 percent.

Copyright Reuters, 2008

Comments

Comments are closed.